Search the Newsreel

M&A Roundup: IntraGel & UroGen Sign Collaboration & Investment Agreements, Lupin & Tenpoint Form Commercialization Collaboration

This M&A roundup highlights two key biopharma agreements. UroGen Pharma has invested up to $7 million in IntraGel Therapeutics, securing an exclusive option to license Tumocure for advanced head and neck cancer and access to IntraGel's SRGel platform. Separately, Lupin Limited's subsidiary, VISUfarma B.V., …

INTRAGEL THERAPEUTICS LTD announced that it expects to receive $7 million in funding from UroGen Pharma Ltd.

INTRAGEL THERAPEUTICS LTD announced that it expects to receive $7 million in funding from UroGen Pharma Ltd. The funding involves UroGen Pharma participating in an investment agreement to purchase convertible preferred stock from IntraGel. This development follows UroGen Pharma's recent submission of a New …

Kroger settles federal disability discrimination lawsuit for $75,000

Kroger Co. has settled a federal lawsuit with the U.S. Equal Employment Opportunity Commission (EEOC) for $75,000. The lawsuit alleged that Kroger failed to accommodate a cashier with a disability at its Edgewood Retail District location and retaliated against her. The settlement includes a …

Urogen Pharma (URGN) Reports Q1 Loss, Beats Revenue Estimates

UroGen Pharma secures option deal with IntraGel for cancer tech

UroGen Pharma has entered into a strategic option and research license agreement with IntraGel Therapeutics, including an equity investment of up to $7 million. This deal grants UroGen exclusive options to develop up to three oncology products utilizing IntraGel's SRGel platform, a biodegradable sustained-release …

UroGen Pharma secures option to license IntraGel SRGel program, agrees up to $7M investment

UroGen Pharma has entered into an agreement with IntraGel, securing an exclusive option to license IntraGel’s SRGel-based TumoCure program for head and neck cancer. This agreement also includes options for additional worldwide licenses to combine SRGel with other compounds, expanding UroGen's potential pipeline. Additionally, …

Neurogene (NGNE) Latest Quarter: Profit Per Share Falls Below Its Benchmark in Latest Trading; Market Response: Shares Finish 10.54% Higher in the Current Update - Full Year Guidance

UroGen Announces Strategic Collaboration and Investment

UroGen Pharma Ltd. has entered into a strategic Option and Research License Agreement and an Investment Agreement with IntraGel Therapeutics, Ltd. This collaboration grants UroGen access to IntraGel's proprietary SRGel platform for developing oncology products and an exclusive option to license TumoCure, an investigational …

Meeder Advisory Services Inc. Acquires Shares of 4,608 Biogen Inc. $BIIB

Meeder Advisory Services Inc. recently acquired 4,608 shares of Biogen Inc. (NASDAQ:BIIB) during the second quarter, valuing the new position at approximately $996,000. This move is part of broader institutional investor activity, with several other firms also modifying their holdings in Biogen. Analysts currently …

Kroger (KR) Stock Looks Like A Bargain On Value But Full On Earnings

Kroger's stock has shown a 36.9% total return over five years but is down 19.9% in the last year, leading to questions about its current valuation. While broad valuation metrics suggest the stock still offers some value, its P/E ratio of 33.0x is above …

Edmond DE Rothschild Holding S.A. Makes New Investment in Biogen Inc. $BIIB

Edmond DE Rothschild Holding S.A. has acquired a new stake in Biogen Inc. (NASDAQ:BIIB), purchasing 56,064 shares valued at approximately $12.11 million during the second quarter. This investment is part of a trend where various institutional investors have either bought new positions or increased …

Deutsche Bank AG Purchases New Holdings in The Kroger Co. $KR

Deutsche Bank AG has acquired a new stake in The Kroger Co. (NYSE:KR), purchasing over 2.1 million shares valued at approximately $119.7 million, representing about 0.35% of Kroger's stock. This move comes as other hedge funds have also adjusted their positions in the company, …

Hydrogen Utopia taps io consulting to accelerate UK SAF and hydrogen projects

REG - Hydrogen Utopia Intl - Master Services Agreement with io consulting

Kroger (KR) Results Review: The Bottom-Line Figure Trails Its Comparison in the Available Record; Investor Response: The Stock Ends Down 0.12% - Share Repurchase Impact

Is Rogers (NYSE:ROG) Gaining Momentum After Its Earnings Improvement?

Is Rogers (ROG) Refocusing Its Portfolio to Build a Higher-Quality Earnings Engine?

Rogers Communications (TSX:RCI.B) Stock Looks Reasonable On Earnings And Rich On Dividends

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Rogers Communications stock has delivered a 6.9% return over the past year, yet current …

City deal sets protest limits outside downtown Kroger amid small business complaints

The city of Cincinnati has brokered a deal to limit protests outside Kroger's downtown headquarters following complaints from nearby businesses and residents about noise and disruption. The demonstrations by Animal Equality, advocating for cage-free animal practices, will now be restricted to a specific time …

How Investors Are Reacting To Rogers Communications (TSX:RCI.B) Completing The CA$300m EORN 5G Expansion

On 20 August 2026, the Eastern Ontario Regional Network and Rogers Communications marked the completion of the CA$300 million EORN Cell Gap Project, a public‑private partnership that expanded 5G cellular coverage across eastern Ontario with federal, provincial, municipal and Indigenous partners. This milestone underscores …

MacroGenics (NASDAQ: MGNX) officer prepares stock sales under Rule 144

Jeffrey Peters, an officer at MacroGenics (NASDAQ: MGNX), has filed a Form 144 indicating his intent to sell common shares acquired through stock plan activity in 2025 and 2026. These shares may be sold through Merrill Lynch on NASDAQ once Rule 144 conditions are …

Biogen Inc. stock outperforms competitors on strong trading day

Shares of Biogen Inc. (BIIB) rose 4.24% to $221.56, outperforming the broader market indices like the S&P 500 Index and the Dow Jones Industrial Average. This marks the second consecutive day of gains for the company's stock. The positive performance occurred during a strong …

Kroger (KR) Stock Looks Reasonable As ECommerce Leadership Changes Start

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Kroger stock has delivered a 37.3% return over the past 5 years, and with the current checks suggesting the shares lean cheap on valuation, …

Is CCOI a Buy as Margins Improve but Refinancing Risks Stay High?

Cogent Communications Holdings, Inc. CCOI offers investors a sharp trade-off. Its valuation is near a five-year low and operating efficiency is improving, but leverage and refinancing needs remain substantial. The investment question is whether growth in higher-margin on-net and wavelength services can strengthen earnings …

CCOI Surges 14% in a Week as Earnings Improve but Risks Persist

Cogent Communications Holdings, Inc. CCOI shares gained 14% in the past week, even after falling 20.2% in the past month and 49.3% in the past three months. The rebound follows a narrower quarterly loss and improving earnings estimates. The setup remains mixed. Service revenues …

Bronstein, Gewirtz & Grossman LLC Urges Cogent Communications Holdings, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Cogent Communications Holdings, Inc. (NASDAQ: CCOI) on behalf of investors who purchased securities between February 29, 2024, and May 1, 2026. The lawsuit alleges that Cogent made materially false and misleading statements …

How Cogent's $225M Data Center Sale Could Reshape Its Debt Strategy

Cogent Fiber, LLC sold 10 data centers for $225 million, providing capital to reduce debt and focus on core telecommunications. This sale helped lower Cogent's net leverage ratio, but the company still faces a significant 2027 refinancing challenge and relies on T-Mobile payments, highlighting …

Graasi Organic Barley Water Debuts in Kroger's Richmond Division Through New Partnership with Brown Distributing

Graasi Organic Barley Water has entered Kroger's Richmond Division, partnering with Brown Distributing to bring its USDA Certified Organic functional beverages to mainstream grocery shelves. This marks Graasi's first entry into Kroger's network, with hopes for broader distribution. The brand offers clean-label, plant-based hydration …

Urogen Pharma stock hits 52-week high at 49.69 USD

Urogen Pharma (URGN) stock has reached a new 52-week high of $49.69, currently trading slightly below this peak at $49.81. This surge reflects an impressive 158.56% increase over the past year and 109% year-to-date returns, driven by strong revenue growth and significant gross profit …

Is It Worth Investing in Kroger (KR) Based on Wall Street's Bullish Views?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter? Before …

Kroger to pay $75,000 in EEOC disability discrimination and retaliation lawsuit

Kroger will pay $75,000 and provide equitable relief to settle a disability discrimination and retaliation lawsuit filed by the U.S. Equal Employment Opportunity Commission (EEOC). The lawsuit alleged that Kroger failed to accommodate a breast cancer survivor cashier who needed to sit during shifts …

Rogers Communications (TSX:RCI.B) Stock Could Be 16% Undervalued On Wildfire Satellite Rollout

Cogent Communications downgraded by JPMorgan as leverage remains elevated (CCOI:NASDAQ)

JPMorgan downgraded Cogent Communications (CCOI) to Underweight from Neutral, causing its shares to fall about 6.3% in premarket trading. The downgrade is attributed to ongoing revenue pressure, execution difficulties in its Waves business, and high leverage.